Compare ANF & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANF | TMDX |
|---|---|---|
| Founded | 1892 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.6B |
| IPO Year | 1996 | 2019 |
| Metric | ANF | TMDX |
|---|---|---|
| Price | $93.68 | $128.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 8 |
| Target Price | $121.82 | ★ $144.25 |
| AVG Volume (30 Days) | ★ 1.4M | 727.1K |
| Earning Date | 03-04-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.16 | ★ 170.70 |
| EPS | ★ 10.47 | 2.54 |
| Revenue | ★ $5,181,407,000.00 | $566,354,000.00 |
| Revenue This Year | $7.51 | $38.73 |
| Revenue Next Year | $4.34 | $20.55 |
| P/E Ratio | ★ $8.95 | $51.20 |
| Revenue Growth | 7.57 | ★ 41.20 |
| 52 Week Low | $65.40 | $62.07 |
| 52 Week High | $133.11 | $156.00 |
| Indicator | ANF | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 37.63 | 46.69 |
| Support Level | $91.13 | $127.00 |
| Resistance Level | $96.00 | $140.72 |
| Average True Range (ATR) | 4.39 | 6.52 |
| MACD | -0.53 | -0.77 |
| Stochastic Oscillator | 4.75 | 23.69 |
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Majority stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.